Novel Nano-Drug Delivery System for Brain Tumor Treatment
Open Access
Abstract
As the most dangerous tumors, brain tumors are usually treated with surgical removal, radiation therapy, and chemotherapy. However, due to the aggressive growth of gliomas and their resistance to conventional chemoradiotherapy, it is difficult to cure brain tumors by conventional means. In addition, the higher dose requirement of chemotherapeutic drugs caused by the blood–brain barrier (BBB) and the untargeted nature of the drug inevitably leads to low efficacy and systemic toxicity of chemotherapy. In recent years, nanodrug carriers have attracted extensive attention because of their superior drug transport capacity and easy-to-control properties. This review systematically summarizes the major strategies of novel nano-drug delivery systems for the treatment of brain tumors in recent years that cross the BBB and enhance brain targeting, and compares the advantages and disadvantages of several strategies.Keywords
Funding Information
- National Natural Science Foundation of China (32101160)
- Shenzhen Science and Technology Program (GXWD20200830123048001)
- Foundation of Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instrument (2020B1212060077)
This publication has 110 references indexed in Scilit:
- Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer TherapyThe Journal of Membrane Biology, 2014
- Choline transporter-targeting and co-delivery system for glioma therapyBiomaterials, 2013
- Temporary Disruption of the Blood–Brain Barrier by Use of Ultrasound and Microbubbles: Safety and Efficacy Evaluation in Rhesus MacaquesCancer Research, 2012
- Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targetingInternational Journal of Nanomedicine, 2012
- Targeted drug delivery to tumors: Myths, reality and possibilityJournal of Controlled Release, 2011
- Cell-mediated drug deliveryExpert Opinion on Drug Delivery, 2011
- Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticlesJournal of Drug Targeting, 2009
- Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activityBlood, 2008
- BLOOD-BRAIN BARRIER DRUG TARGETING: THE FUTURE OF BRAIN DRUG DEVELOPMENTMolecular Interventions, 2003
- JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAINJournal of Cell Biology, 1969